Full Breakdown
Understanding ADHD Diagnosis: Insights from the UK and Australia
3/9/2026, 3:04:45 AM
No Evidence of Over-Diagnosis in the UK
A recent study published in the *British Journal of Psychiatry* by experts from the University of Cambridge and the University of Southampton asserts that there is no substantial evidence indicating that Attention Deficit Hyperactivity Disorder (ADHD) is being over-diagnosed in the UK. Professor Tamsin Ford, a senior co-author, emphasized that while more individuals with ADHD are being recognized and treated, many remain unsupported due to misdiagnosis and long waiting times, particularly in the private sector. The study highlights that the prevalence of ADHD is around 5% in children and 3% in adults globally, yet NHS data suggests many individuals in the UK are undiagnosed.
Challenges in Diagnosis and Treatment
The researchers pointed out that misdiagnosis can occur, especially when assessments rely heavily on self-reporting. However, they argue that the predominant issues are under-diagnosis and under-treatment. Professor Samuele Cortese noted the ethical implications of failing to provide effective treatments, which can lead to serious long-term risks such as academic failure and substance abuse. The study calls for improved funding and workforce training to enhance the accuracy of diagnoses and expand access to care.
Changes in ADHD Diagnosis in Australia
In Australia, the landscape of ADHD diagnosis is evolving, particularly as awareness of adult ADHD increases. General practitioners (GPs) are now being trained to diagnose and prescribe medications for ADHD, responding to a surge in late-stage diagnoses among adults. The annual government expenditure on ADHD medications has significantly increased, from $60 million in 2019-2020 to $223 million in 2025-2026. However, the process for obtaining a diagnosis varies by state, with some GPs allowed to diagnose without additional training, while others must complete specific training programs.
Variability in Access and Training
The Australian approach to ADHD diagnosis requires that assessments be comprehensive, considering a person’s social and psychological circumstances. While some states have initiated training programs for GPs, concerns remain regarding the adequacy of remuneration for these services, which may lead to additional out-of-pocket costs for patients. Dr. Tim Senior, a GP, noted that many practitioners are hesitant to take on ADHD cases due to the potential for increased workload and practice viability issues.
Criticism and Opposition
Despite the push for improved access to ADHD diagnosis and treatment, critics argue that the current measures may not sufficiently address the needs of those with ADHD. The reliance on telehealth services, which can be costly, raises concerns about equitable access to care. Additionally, the limited number of trained GPs may hinder the effectiveness of these initiatives, particularly in underserved communities.
Verbatim Quotes
- “While many more people with ADHD are being recognised and treated, we are failing to support many more. Overdiagnosis is not a problem, but misdiagnosis may be as people are driven into the private sector by long waits; and sadly, missed diagnoses remain common.” — Professor Tamsin Ford, University of Cambridge
- “They include increased risk of academic failure, suicidal behaviour, substance abuse, criminality, injury and death. The failure to provide treatments which have been shown to reduce these risks represents a major ethical issue that needs to be urgently addressed.” — Professor Samuele Cortese, University of Southampton
What's Next
As the conversation around ADHD diagnosis continues, both the UK and Australia are urged to focus on improving diagnostic accuracy and treatment access. Ongoing research and policy discussions will likely shape future strategies to address the challenges faced by individuals with ADHD.
